Artikel

Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.

Being diagnosed with type 1 diabetes at the age of 18 is a life-altering experience for most people. But when, like Lucas, you receive three other diagnoses within a few months, it can feel overwhelming. Living with type 1 diabetes becomes even more challenging when you also have autism.

Three years ago, Tina’s 13-year-old son was diagnosed with type 1 diabetes. It was a harrowing ordeal, as he was rushed to the hospital with severe diabetic ketoacidosis. Even today, the entire family remains deeply affected by the traumatic experience.

What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?

As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives⁸.

Anti-islet autoantibodies that target proteins associated with beta-cells serve as biomarkers of autoimmune type 1 diabetes (T1D) development.¹ The number of detectable autoantibodies through screening correlates with risk of developing autoimmune T1D.² Assays for detecting autoimmune T1D have shown high sensitivity and specificity.^3,4

Explore the distinct clinical manifestations of Atopic Dermatitis (AD) and Prurigo Nodularis (PN), their impact on patients' lives, and the common thread of type 2 inflammation. Understand how these chronic skin conditions differ and intersect in this comprehensive overview.

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

Practical Guidance based on the 2022 ADA/EASD Guidelines.

Know the signs and symptoms of acquired TTP (aTTP).